Zimmer Biomet's robust Knee business appears promising. However, a dull macroeconomic condition adds to the worry.

Internationally, Zimmer Biomet secured CE mark approval for Persona Revision in late 2024. Already established as the leading revision knee implant in the United States, this product is projected ...

Several spine and orthopedic companies have made progress with acquisitions in the first quarter of 2025. 1. Stryker has ...

Modular Devices, a leading provider of mobile and modular medical imaging and cleanrooms solutions, today announces the appointment of Chris Basey as Chief Commercial Officer (CCO) for Modular Devices ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This was the stock's second consecutive day of gains.